Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-14

Clinical Trial Update: Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment [NA]

View source ↗

Summary

Hadassah Medical Organization is conducting a study to identify characteristic signatures of Attention Deficit Hyperactivity Disorder and to evaluate Ritalin (m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ritalin (methylphenidate)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: "Attention Deficit Hyperactivity Disorder" | NA | Status: UNKNOWN